Chicago, United States, 5 May 2010
Today EuropaBio hosts a high-level workshop on Health Technology Assessment (HTA) at the
International BIO Conference in Chicago.
HTA is the process of assessing the value of medical technologies on the basis of which
governments take decisions on whether to grant patient access to them. The EuropaBio
workshop will bring together high level policy makers and industry specialists from across Europe